![](/img/cover-not-exists.png)
O-39 HER2 positive early breast cancers: What proportion are receiving adjuvant Trastuzumab therapy? A multicentre audit
S. Marla, J. Cardale, D.J. Dodwell, A.I. Skene, O. Gojis, P. Abram, C. Palmieri, S.J. Cleator, A. Bowman, J.C. DoughtyVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/j.ejcsup.2010.06.040
File:
PDF, 42 KB
english, 2010